Feasibility of Telaprevir-Based Triple Therapy in Liver Transplant Patients with Hepatitis C Virus: SVR 24 Results

• Christoph R. Werner ,

  Contributed equally to this work with: Christoph R. Werner, Daniel P. Egetemeyr

  Affiliation Medical Clinic, Department of Gastroenterology, Hepatology, and Infectiology, University Hospital Tuebingen, Tuebingen, Germany

  ⨯
• Daniel P. Egetemeyr ,

  Contributed equally to this work with: Christoph R. Werner, Daniel P. Egetemeyr

  Affiliation Medical Clinic, Department of Gastroenterology, Hepatology, and Infectiology, University Hospital Tuebingen, Tuebingen, Germany

  ⨯
• Ulrich M. Lauer,

  Affiliation Medical Clinic, Department of Gastroenterology, Hepatology, and Infectiology, University Hospital Tuebingen, Tuebingen, Germany

  ⨯
• Silvio Nadalin,

  Affiliation Department of General, Visceral and Transplant Surgery, University Hospital Tuebingen, Tuebingen, Germany

  ⨯
• Alfred Königsrainer,

  Affiliation Department of General, Visceral and Transplant Surgery, University Hospital Tuebingen, Tuebingen, Germany

  ⨯
• Nisar P. Malek,

  Affiliation Medical Clinic, Department of Gastroenterology, Hepatology, and Infectiology, University Hospital Tuebingen, Tuebingen, Germany

  ⨯
• Christoph P. Berg

  * E-mail: christoph.berg@med.uni-tuebingen.de

  Affiliation Medical Clinic, Department of Gastroenterology, Hepatology, and Infectiology, University Hospital Tuebingen, Tuebingen, Germany

  ⨯